The instructor in neurology at Beth Israel Deaconess Medical Center spoke about what clinicians can do right now to mitigate the risk of SUDEP and the myriad of options for them to utilize.
Daniel M. Goldenholz, MD, PhD
Advertisement
Articles by Daniel M. Goldenholz, MD, PhD
Advertisement
Latest Updated Articles
Daniel M. Goldenholz, MD, PhD: Assessing the Risk for SUDEPPublished: December 4th 2018 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Anti-MTBR Tau Antibody Etalanetug Given FDA Fast Track Designation
2
Earlier Initiation of Pimavanserin Leads to Better Improvement of Parkinson Disease Psychosis Symptoms
3
MDS Congress 2025: Top Expert Interviews and Key Takeaways
4
Emerging Neuroprotective Agents for Stroke Care
5
